zeposia
bristol-myers squibb pharma eeig - ozanimod hidroklorid - multiple sclerosis, relapsing-remitting; colitis, ulcerative - imunosupresivi - multiple sclerosiszeposia is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (rrms) with active disease as defined by clinical or imaging features. ulcerative colitiszeposia is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (uc) who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biologic agent.
fluarix tetra suspenzija za injekciju u napunjenoj štrcaljki, cjepivo protiv influence (fragmentirani virion), inaktivirano
glaxosmithkline biologicals s.a., rue de l'institut 89, rixensart, belgija - soj virusa influence (inaktivirani, fragmentirani) tip a (h1n1) soj virusa influence (inaktivirani, fragmentirani) tip a (h3n2) soj virusa influence (inaktivirani, fragmentirani) tip b - suspenzija za injekciju u napunjenoj štrcaljki - 1 doza = 0,5 ml - urbroj: 1 doza (0,5 ml) sadrži 15 mikrograma hemaglutinina po soju virusa influence (inaktivirani, fragmentirani) za sezonu aktualnih sojeva tip a (h1n1), tip a (h3n2) i dva soja tipa b
metopirone 250 mg meke kapsule
hra pharma rare diseases, 200 avenue de paris, chatillon, francuska - metirapon - kapsula, meka - 250 mg - urbroj: jedna kapsula sadrži 250 mg metirapona
skudexa 75 mg/25 mg filmom obložene tablete
menarini international operations luxembourg s.a., 1, avenue de la gare, luksemburg, luksemburg - tramadolklorid deksketoprofentrometamol - filmom obložena tableta - 75 mg + 25 mg - urbroj: jedna tableta sadrži 75 mg tramadolklorida i 25 mg deksketoprofena
skudexa 75 mg/25 mg granule za oralnu otopinu u vrećici
menarini international operations luxembourg s.a., 1, avenue de la gare, luksemburg, luksemburg - tramadolklorid deksketoprofentrometamol - granule za oralnu otopinu - 75 mg + 25 mg - urbroj: jedna vrećica sadrži: 75 mg tramadolklorida i 25 mg deksketoprofena (u obliku deksketoprofentrometamola).
efluelda, suspenzija za injekciju u napunjenoj štrcaljki, četverovalentno cjepivo protiv influence (fragmentirani virion, inaktivirano), 60 mikrograma ha/soju
sanofi pasteur, 14 espace henry vallee, lyon, francuska - soj virusa influence (inaktivirani, fragmentirani) tip a (h1n1) soj virusa influence (inaktivirani, fragmentirani) tip a (h3n2) soj virusa influence (inaktivirani, fragmentirani) tip b - suspenzija za injekciju u napunjenoj štrcaljki - 1 doza = 0,7 ml - urbroj: 1 doza (0,7 ml) sadrži 60 mikrograma hemaglutinina po soju virusa influence (inaktivirani, fragmentirani) za sezonu aktualnih sojeva tip a (h1n1), tip a (h3n2) i dva soja tipa b
ozawade
bioprojet pharma - pitolisant - sleep apnea, obstructive - ostali lijekovi protiv živčanog sustava - ozawade is indicated to improve wakefulness and reduce excessive daytime sleepiness (eds) in adult patients with obstructive sleep apnoea (osa).
olumiant
eli lilly nederland b.v. - baricitinib - artritis, reumatoidni - imunosupresivi - rheumatoid arthritisbaricitinib is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease modifying anti rheumatic drugs (dmards). olumiant se može koristiti kao monoterapija ili u kombinaciji s metotreksatom. atopic dermatitisolumiant is indicated for the treatment of moderate to severe atopic dermatitis in adult and paediatric patients 2 years of age and older who are candidates for systemic therapy. alopecia areatabaricitinib is indicated for the treatment of severe alopecia areata in adult patients (see section 5. juvenile idiopathic arthritisbaricitinib is indicated for the treatment of active juvenile idiopathic arthritis in patients 2 years of age and older who have had an inadequate response or intolerance to one or more prior conventional synthetic or biologic dmards:- polyarticular juvenile idiopathic arthritis (polyarticular rheumatoid factor positive [rf+] or negative [rf-], extended oligoarticular),- enthesitis related arthritis, and- juvenile psoriatic arthritis. baricitinib may be used as monotherapy or in combination with methotrexate.
namuscla
lupin europe gmbh - mexiletine hydrochloride - Миотонических poremećaja - srčana terapija - namuscla indiciran za simptomatsko liječenje миотонии u odraslih bolesnika s non-дистрофические миотонических poremećaja.
ibustar za djecu 20 mg/ml oralna suspenzija
berlin-chemie ag, glienicker weg 125, berlin, njemačka - ibuprofen - oralna suspenzija - 20 mg/ml - urbroj: svaki ml oralne suspenzije sadrži 20 mg ibuprofena